Paul Ingravallo - Concepedia

Author

Paul Ingravallo

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Howe, Anita Y., P Ingravallo, P. INGRAVALLO, P. Ingravallo, Paul Ingravallo

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)WuXi AppTec (China)New York University Emory University United States Military Academy

About

Paul Ingravallo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	28	1.9K
2	Natural Sciences	11	11	694
3	Biochemistry	9	9	680
4	Engineering	1	1	16
5	Biology	1	1	55

Paul Ingravallo

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. John W. Barnwell, Adam S. Asch, Ralph L. Nachman, Journal of Clinical Investigation Plasmodium Falciparum-infected ErythrocytesMr 88,000Cytoadherence LigandImmunologyHematology	1989	373
A reticulocyte-binding protein complex of plasmodium vivax merozoites Mary R. Galinski, Claudia Corredor Medina, Paul Ingravallo, Cell Protein FunctionBiochemistryNatural SciencesMedicineMalaria	1992	372
SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells Bruce A. Malcolm, R. Liu, Frederick Lahser, Antimicrobial Agents and Chemotherapy Viral ReplicationHepatitis C VirusImmunologyMolecular BiologyHcv Replication	2006	316
Discovery of (1 <i>R</i> ,5 <i>S</i> )- <i>N</i> -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( <i>S</i> )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( <i>S</i> )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection Srikanth Venkatraman, Stéphane Bogen, Ashok Arasappan, Journal of Medicinal Chemistry	2006	278
Two <i>Plasmodium falciparum</i> genes express merozoite proteins that are related to <i>Plasmodium vivax</i> and <i>Plasmodium yoelii</i> adhesive proteins involved in host cell selection and invasion Julian C. Rayner, Mary R. Galinski, Paul Ingravallo, Proceedings of the National Academy of Sciences	2000	162
Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors David R. McGivern, Takahiro Masaki, Sara E. Williford, Gastroenterology BiochemistryViral HepatitisMedicineAntiviral Drug DevelopmentAntiviral Therapy	2014	107
Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain Mary R. Galinski, Claudia Corredor-Medina, Marinette M. Povoa, Molecular and Biochemical Parasitology	1999	105
Extensive polymorphism in the <i>Plasmodium vivax</i> merozoite surface coat protein MSP-3α is limited to specific domains Julian C. Rayner, Vladimir Corredor, Daniel D. Feldman, Parasitology	2002	80
Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir Rong Liu, Stephanie Curry, Patricia McMonagle, Antimicrobial Agents and Chemotherapy	2015	76
Plasmodium vivax merozoite surface proteins-3β and-3γ share structural similarities with P. vivax merozoite surface protein-3α and define a new gene family Mary R. Galinski, Paul Ingravallo, Claudia Corredor-Medina, Molecular and Biochemical Parasitology GeneticsMalariaMerozoite Surface Protein-3αMolecular BiologyParasite Genomics	2001	63

Page 1